ADAM10 and infection: To further investigate the role of endothelial ADAM10 as an inciting factor in microvascular injury in vivo following infection with P. aeruginosa or S. pneumoniae, we examined whether the use of the ADAM10 active site inhibitor GI254023X could prevent pathogen-induced platelet aggregation on the injured endothelium.